Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Bath & Body Works To See More Comfort In Second Half Numbers With Further Improvement: Analysts

Published 05/06/2024, 20:27
Updated 05/06/2024, 21:41
© Reuters.  Bath & Body Works To See More Comfort In Second Half Numbers With Further Improvement: Analysts
BBWI
-

Benzinga - by Nabaparna Bhattacharya, Benzinga Editor.

Bath & Body Works, Inc. (NYSE:BBWI) recently reported its first-quarter FY24 results, in which inventories increased 5.6% year over year to $814 million.

Here’s a glimpse into analysts’ reactions to the company’s quarterly performance:

  • Goldman Sachs analyst Kate McShane reiterated a Buy rating with a price forecast of $60.
  • BMO Capital Market analyst Simeon Siegel reiterated the Outperform rating, raising the price forecast to $55 from $50.
  • JP Morgan analyst Matthew R. Boss reiterated a Neutral rating with a price forecast of $53.
  • BofA Securities analyst Lorraine Hutchinson reiterated Buy rating, with a price objective of $54.
Goldman Sachs: According to the analyst, the top line came in above expectations, driven by continued newness. However, category trends were mixed, with strength in body care.

McShane reiterated the Buy rating even with a weighted guidance for the second half of the year, given the number of initiatives the company has for growth, including its robust pipeline of product ideas and newness and the rollout of category adjacencies.

BMO: Analyst Siegel highlighted questions surrounding the revenue decline the company would face as it laps its incredible pandemic strength.

However, the analyst said Bath & Body Works is progressing exactly as one would hope a turn would look, providing more comfort in 2H numbers and further improvement.

This continues to suggest that the company is under-earning and its valuation trough should increase into the double-digit PE range.

JP Morgan: Analyst Matthew R. Boss highlighted the combination of normalizing same-store-sales relative to pre-pandemic, coupled with high-single-digit comp growth.

In addition, management confirmed May AURs tracking “on plan” for Flat AUR expectations.

BofA Securities: Following the quarterly results, the analyst trimmed the FY24 EPS estimate by 3% to $3.24 but modeled no change to the FY25 estimate of $4.

Product newness is working, with body care growing LSD driven by men’s, travel, lip, and Fine Fragrance Mist.

Fine Fragrance Mist was a test and will now roll out to the entire fleet in the second half, the analyst adds.

Continued growth in core categories and expansion in new adjacencies should drive positive total sales growth by the third quarter, Hutchinson adds.

Price Action: BBWI shares are trading higher by 3.74% to $46.86 at last check Wednesday.

Read Next:United Airlines Hits Brakes On Hiring This Year Due To Boeing Woes: Report

Photo via Wikimedia Commons

Latest Ratings for BBWI

DateFirmActionFromTo
Feb 2022Credit SuisseMaintainsNeutral
Feb 2022B. Riley SecuritiesMaintainsBuy
Feb 2022Morgan StanleyMaintainsOverweight
View More Analyst Ratings for BBWI

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.